Type 2 diabetes mellitus: Isn’t it time to update the terminology?

Figure 3 Diagram showing the spectrum of disease coming under adiposity-induced metabolic dysfunction associated disease. AMAD: Adiposity-induced metabolic dysfunction associated disease; MAED: Metabolic dysfunction associated endocrine diseases; MACVD: Metabolic dysfunction associated cardiovascular diseases; MAGD: Metabolic dysfunction associated gastrointestinal diseases; MAHBD: Metabolic dysfunction associated hepatobiliary diseases; MAND: Metabolic dysfunction associated neurological diseases; MAGUD: Metabolic dysfunction associated genitourinary diseases; MACD: Metabolic dysfunction associated circulatory diseases; MARD: Metabolic dysfunction associated respiratory diseases; MAMSD: Metabolic dysfunction associated musculoskeletal diseases; MAID: Metabolic dysfunction associated immune diseases; MASD: Metabolic dysfunction associated sexual diseases/dysfunction; MAIgD: Metabolic dysfunction associated integumentary disease.